Effect of teriflunomide on Epstein–Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study-Reference-Cited by-同舟云学术

Effect of teriflunomide on Epstein–Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study

Published:2022-12 Issue: Volume:68 Page:104377
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Gold Julian,Holden David,Parratt John,Yiannikas Con,Ahmad Raghib,Sedhom Mamdouh,Giovannoni Gavin

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference17 articles.

1. Infectious mononucleosis;Balfour;Clin. Transl. Immunol.,2015

2. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis;Bjornevik;Science,2022

3. Epstein-Barr virus in salivary samples from systemic lupus erythematosus patients with oral lesions;Buonavoglia;J. Clin. Med.,2021

4. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis;Gieß;PLoS One,2017

5. A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study;Gold;Mult. Scler. Relat. Disord.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis;Multiple Sclerosis Journal;2023-12-22

2. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review;Multiple Sclerosis and Related Disorders;2023-12

3. A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis;2023-08-20